A new air passenger screening program announced today will provide early detection of influenza, RSV, and about thirty respiratory viruses.
Confirmed on November 6, 2023, the U.S. CDC's Traveler-based Genomic Surveillance (TGS) program has tested about 360,000 air travelers from more than 135 countries.
Individual samples collected from air travelers provide the most granular and reliable data for detecting pathogens. All samples are voluntary and de-identified.
Read More
